The 10 references in paper A. Pirogov B., V. Kolosov P., Yu. Perel'man M., A. Prikhod'ko G., S. Zinov'ev V., D. Gassan A., T. Mal'tseva A., А. Пирогов Б., В. Колосов П., Ю. Перельман М., А. Приходько Г., С. Зиновьев В., Д. Гассан А., Т. Мальцева А. (2017) “Особенности воспалительных паттернов бронхов и клинико-функциональная характеристика тяжелой неконтролируемой астмы у больных с холодовой гиперреактивностью дыхательных путей // Airway inflammation patterns and clinical and functional features in patients with severe uncontrolled asthma and cold-induced airway hyperresponsiveness” / spz:neicon:pulmonology:y:2016:i:6:p:701-707

1
Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention (Updated 2016). Available at: http:// www.ginasthma.com
(check this in PDF content)
2
Reddel H.K., Taylor D.R., Bateman E.D. et al. An official American Thoracic Society / European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am. J. Respir. Crit. Care Med.2009; 180 (1): 59–99. Available at: http:// www.atsjournals.org/doi/full/10.1164/rccm.200801060ST#.V-C4aIiLRMw
(check this in PDF content)
3
Федосеев Г.Б., Трофимов В.И., Петрова М.А. Многоликая бронхиальная астма. Диагностика, лечение и профилактика. СПб: Нордмедиздат; 2011.
(check this in PDF content)
4
Chung K.F., Wenzel S.E., Brozek J.L. et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur. Respir. J.2014; 43 (2): 343–373. Available at: http://erj.ersjournals.com/content/43/2/343. long
(check this in PDF content)
5
Федосеев Г.Б., Трофимов В.И., Шапорова Н.Л. и др. В поисках истины: что такое бронхиальная астма? Пульмонология. 2015; 25 (1): 5–18. Available at: http:// journal.pulmonology.ru/pulm/article/view/518/488/
(check this in PDF content)
6
Hastie A.T., Moore W.C., Meyers D.A. et al. Аnalyses of asthma severity phenotypes and inflammatory proteins in subjects stratified by sputum granulocytes. J. Allergy Clin. Immunol.2010; 125 (5): 1028–1036. Available at: https:// www.ncbi.nlm.nih.gov/pmc/articles/PMC2878277/
(check this in PDF content)
7
Barnes P.J. Glucocorticosteroids: current and future directions. Br. J. Pharmacol. 2011; 163 (1) 29–43. Available at: https:// www.ncbi.nlm.nih.gov/pmc/articles/PMC3085866/
(check this in PDF content)
8
Jarjour N.N., Erzurum S.C., Bleecker E.R. et al. Severe asthma: lessons learned from the National Heart, Lung, and Blood Institute Severe Asthma Research Program.Am. J. Respir. Crit. Care Med. 2012; 185 (4): 356–362. Available at: https:// www.ncbi.nlm.nih.gov/pmc/articles/PMC3297096/
(check this in PDF content)
9
Trevor J.L., Deshane J.S. Refractory asthma: mechanisms, targets, and therapy. Allergy. 2014; 69 (7): 817–827. Available at:https://www.ncbi.nlm.nih.gov/pmc/articles/ PMC4279947/
(check this in PDF content)
10
Wood L.G., Baines K.I., Fu J. et al. The neutrophilic inflammatory phenotype is associated with systemic inflammation in asthma. Chest. 2012; 142 (1): 86–93. Available at: Таблица 4 Цитоморфологические показ
(check this in PDF content)